Cefuroxime Injection, Powder, For Solution
Product Images NDC 0143-9977

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cefuroxime (NDC 0143-9977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefuroxime For Injection Usp 1

Cefuroxime For Injection Usp 1
Chemical structure of Cefuroxime shown as a detailed molecular diagram with rings, bonds, and atomic groupings.*
FDA Label Image

Cefuroxime For Injection Usp 2

Cefuroxime For Injection Usp 2
Cefuroxime for Injection, USP 750 mg powder for solution, labeled for intravenous or intramuscular use. The label shows dosage instructions, storage conditions, and manufacturer details. The product is by Hikma Pharmaceuticals USA Inc., with information about reconstitution and suspension preparation included.*
FDA Label Image

Cefuroxime For Injection Usp 3

Cefuroxime For Injection Usp 3
Label for Cefuroxime for Injection, USP 750 mg per vial by Hikma Pharmaceuticals USA Inc. The label indicates the powder for solution dosage form intended for intravenous or intramuscular use. The package contains 25 vials of 750 mg each. Instructions and storage information are printed on the label along with NDC 0143-9979-22.*
FDA Label Image

Cefuroxime For Injection Usp 4

Cefuroxime For Injection Usp 4
This packaging label is for Cefuroxime for Injection, USP, with a strength of 1.5 g per vial. The label states it is for intravenous use only. The container size is 1 vial. The labeler is Hikma Pharmaceuticals USA Inc. Additionally, the label includes drug storage instructions and dilution directions for use.*
FDA Label Image

Cefuroxime For Injection Usp 5

Cefuroxime For Injection Usp 5
Cefuroxime for Injection, USP 1.5 g per vial label for injection powder for solution. Intended for intravenous use only, the label includes usage instructions and storage information. Manufactured by Hikma Pharmaceuticals USA Inc. The label displays the NDC 0143-9977-22 and indicates that the product contains 25 vials of 1.5 g strength each.*
FDA Label Image

Cefuroxime For Injection Usp 6

Cefuroxime For Injection Usp 6
A rectangular label containing a QR code on the left side and alphanumeric batch information on the right. The text includes GTIN, serial number, expiration date (expiration format indicated as MMYYYY), and lot number details in black font on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.